Mylan Inc’s (NASDAQ:MYL) Sentiment is 1

June 27, 2018 - By Heather Owens

Mylan N.V. (NASDAQ:MYL) Corporate Logo

“Big money” Positions

“Big money sentiment for Mylan Inc (NASDAQ:MYL) in Q1 2018 decreased to 1, according to SEC filings. So its down -2.00, from 2017Q4’s 3. 3 investment professionals increased or started new holdings, while 3 sold and trimmed stakes in Mylan Inc so the sentiment dived. These funds own 190,596 shares, that’s down from 292,846 shares in 2017Q4. Funds holding Mylan Inc in top 10 was flat from 0 to 0 for the same number . 1 Investors Sold All; 2 Reduced Holdings; 0 increased holdings while 3 investment professionals bought holdings.

Significant Mylan Inc Investors

Van Hulzen Asset Management Llc owns 30,685 shares in Mylan Inc as of Q1 2018. Mylan Inc’s shareholder Gulf International Bank (Uk) Ltd owns 139,000 shares as of Q1 2018. Eqis Capital Management Inc. reported 6,506 shares. The California-based fund Gemmer Asset Management Llc have invested about 0% of the investment manager’s stock portfolio in Mylan Inc. The Pennsylvania-based fund Vantage Investment Advisors Llc holds 337 shares or 0% of their long stock exposure.

Mylan N.V., together with its subsidiaries, develops, licenses, makes, markets, and distributes generic, brand name, and over-the-counter products worldwide.The firm is worth $19.82 billion. The firm operates through three divisions: North America, Europe, and Rest of World.28.39 is the P/E ratio. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.

MYL is touching $38.44 during the last trading session, after increased 0.39%.Mylan N.V. has volume of 1.25 million shares. Since June 27, 2017 MYL has declined 1.13% and is downtrending. The stock underperformed the S&P500 by 13.70%.

Earnings report for Mylan N.V. (NASDAQ:MYL) is expected on August, 8., according to Zacks. Analysts predict 11.82 % diference or $1.23 from the $1.1 EPS from 2017. In case of $1.23 earnings per share MYL’s profit could reach $634.04 million. Analysts at Wall Street see Mylan N.V.’s 28.13 % EPS growth compared to $0.96 earnings per share for previous quarter.

Van Hulzen Asset Mgmt Ltd Com reported 30,685 shs. California-based Eqis Cap Mngmt has invested 0.01% in Mylan N.V. (NASDAQ:MYL). Gemmer Asset Management Lc stated it has 12 shs. 337 were accumulated by Vantage Advisors Limited Liability Company. Gulf Commercial Bank (Uk) Limited reported 0.07% stake.

Mylan N.V. (NASDAQ:MYL) Ratings Coverage

In total 15 analysts cover Mylan (NASDAQ:MYL). “Buy” rating has 11, “Sell” are 0, while 4 are “Hold”. (NASDAQ:MYL) has 73% bullish analysts. With $5900 highest and $41 lowest target, Mylan has $49.67 average target or 29.21% above the current ($38.44) price. 20 are the (NASDAQ:MYL)’s ratings reports on 27 Jun 2018 according to StockzIntelligence Inc. The stock rating was maintained by Mizuho with “Buy” on Thursday, March 15. On Thursday, March 1 the stock of Mylan N.V. (NASDAQ:MYL) has “Hold” rating given by Cantor Fitzgerald. On Thursday, April 12 the stock of Mylan N.V. (NASDAQ:MYL) has “Buy” rating given by Mizuho. On Tuesday, February 6 the rating was maintained by BMO Capital Markets with “Buy”. The stock rating was upgraded by Goldman Sachs to “Buy” on Thursday, January 11. On Thursday, May 31 the firm has “Market Perform” rating by Wells Fargo given. On Thursday, January 4 the company was maintained by Citigroup. On Tuesday, March 6 the stock of Mylan N.V. (NASDAQ:MYL) has “Overweight” rating given by Morgan Stanley. On Tuesday, June 5 the stock has “Buy” rating by Guggenheim. On Thursday, January 18 the company was maintained by Mizuho.

A couple more Mylan N.V. (NASDAQ:MYL) news were released by: Streetinsider.com which released on June 18, 2018 “Mylan (MYL) Announces Launch of Generic Angiomax Injection”, also Seekingalpha.com on June 04, 2018 released “Mylan: A Margin Of Safety Case Study”, the next Fool.com is “Watch Out Amgen, Here Comes Mylan” on June 05, 2018. Streetinsider.com has article titled “Mylan (MYL) Removed from Citi’s US Focus List”.

Mylan N.V. (NASDAQ:MYL) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.